Issue Date: September 29, 2011
Issued by: Center for Veterinary Medicine
Topic(s): Target Animal – Effectiveness, Target Animal – Safety
Status: Final
CVM GFI #215 Target Animal Safety & Effectiveness Protocol Development & Submission
To facilitate the drug development process, the Center for Veterinary Medicine (CVM) recommends that sponsors submit protocols to CVM’s Office of New Animal Drug Evaluation’s (ONADE) Division of Therapeutic Drugs for Non-Food Animals, Division of Production Drugs, or Division of Therapeutic Drugs for Food Animals to review study designs before initiating a study to support substantial evidence of effectiveness or target animal safety. This guidance makes recommendations to aid in the preparation of protocols used to generate data to support new animal drug applications, specifically target animal safety and substantial evidence of effectiveness. The recommendations are intended to reduce the time to protocol concurrence by: • Recommending a path to protocol concurrence, • Enhancing quality of protocol submissions by focusing on agreements on study design and statistical analysis, and • Making use of opportunities to meet with CVM before and during protocol development.
Download the Guidance Document
